LotusSonic® (Lotosonic®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Similar drugsTo uncover
Dosage form: & nbsptfilm-covered laths
Composition:

Each tablet contains:

Active components:

Extract of thick 177.1 mg from the mixture:

Dioscorei rhizomes (Dioscorea persimilis L.)

183.0 mg

The lotus of nut-bearing seeds (Nelumbium nucifemm Garth.)

175.0 mg

Lotus nut-bearing embryos (Nelumbium nuciferum Garth.)

15.0 mg

Tui of eastern seeds (Biota orientalis L.)

91.25 mg

Extract of thick 80.5 mg from the mixture:

The date of Chinese seeds (Zizyphus jujube Mill.)

91.25 mg

Mulberry leaves (Morus alba L.)

91,25 mg

Erythrins of leaves (Erythrina orientalis L.)

91,25 mg

Euphoria of longa fruit (Euphoria longana Lamk.)

91.25 mg

Excipients: lactose, magnesium stearate, silicon dioxide colloid (aerosil), microcrystalline cellulose, hypromellose, sodium carboxymethyl starch.

Sheath: talc, titanium dioxide, macrogol 6000, blue dye patented (E 131).

Description:

Round tablets of biconvex form, covered with a film shell of blue color. The core of the tablet is brownish-gray with numerous white impregnations and from light yellow to dark brown in color.

Pharmacotherapeutic group:Herbal origin means
Pharmacodynamics:

Combined preparation of plant origin, has a sedative, hypnotic effect, has anxiolytic and anti-stress activity.

Extracts of dates Chinese, lotus, longon, thuja and erythrine have a sedative effect, reduce irritation and tension,The manifestations of mental fatigue and neurasthenia; when insomnia helps restore normal sleep.

Extracts of dioscorea, mulberry and euphoria longans along with the sedative effect also have a vasodilating effect, improve metabolic processes.

Indications:

With increased excitability, irritability, lability of mood, directly in emotional and physical trauma, with a state of constant mental tension, overstrain (so-called "manager's syndrome"), with insomnia (light forms).

Contraindications:

Hypersensitivity to the components of the drug, pregnancy, the period of breastfeeding, age (under 18 years).

Carefully:PIn acute pancreatitis.
Dosing and Administration:

Adults take 1 tablet 2 times a day; when insomnia - 1 hour before bedtime, 1 tablet.

The course of treatment is 30 days.

If necessary, it is possible to conduct a repeated course of treatment on the recommendation of a doctor.

Side effects:

Allergic reactions are possible.

Overdose:

Symptoms: drowsiness, lethargy, feeling depressed, nausea.

Treatment: gastric lavage, symptomatic therapy.

Interaction:

Strengthens the effect of drugs that depress the central nervous system (including hypnotics), hypotensive, analgesic drugs (requires correction of their doses).

Effect on the ability to drive transp. cf. and fur:

During the treatment period, it is necessary to refrain from activities requiring increased attention and quick motor and mental reactions (driving, control of mechanisms).

Form release / dosage:

The tablets covered with a cover.

Packaging:

For 10 tablets in aluminum / PVC blisters.

For 1 or 2 blisters together with instructions for medical use placed in a cardboard box.

Storage conditions:

In dry, the dark place at a temperature of 1 5-25 C.

Keep out of the reach of children.
Shelf life:

3 years.

Do not use after the expiration date.

Terms of leave from pharmacies:Without recipe
Registration number:LS-001320
Date of registration:24.06.2010
Expiration Date:Unlimited
The owner of the registration certificate:Danafa Pharmaceutical Joint Stock Company Danafa Pharmaceutical Joint Stock Company Vietnam
Manufacturer: & nbsp
Representation: & nbspDominanta-Service CJSCDominanta-Service CJSC
Information update date: & nbsp20.03.2018
Illustrated instructions
    Instructions
    Up